HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Charalampos Pontikoglou Selected Research
Charalampos Pontikoglou Research Topics
Disease
9
Neutropenia
10/2017 - 03/2006
6
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2021 - 03/2010
3
Thrombocytopenia (Thrombopenia)
02/2022 - 03/2011
2
Mucormycosis
11/2018 - 01/2018
1
Thrombosis (Thrombus)
02/2022
1
Ischemia
02/2022
1
Neoplasms (Cancer)
11/2021
1
Thrombotic Microangiopathies
03/2021
1
COVID-19
03/2021
1
Hemolytic Anemia
03/2021
1
Pneumonia (Pneumonitis)
03/2021
1
Urinary Bladder Neoplasms (Bladder Cancer)
03/2021
1
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021
1
Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
01/2021
1
Hematologic Diseases (Blood Diseases)
02/2019
1
Cytopenia
02/2019
1
Hematologic Neoplasms (Hematological Malignancy)
02/2019
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
12/2017
1
Paraproteinemias (Monoclonal Gammopathy)
12/2017
1
Necrosis
04/2016
1
Thyroid Diseases (Thyroid Disease)
06/2015
1
Hypothyroidism
06/2015
1
Graves Disease (Basedow Disease)
06/2015
1
Goiter
06/2015
1
Hashimoto Disease (Thyroiditis, Hashimoto)
06/2015
1
Myocardial Infarction
01/2014
1
Aplastic Anemia (Anemia, Hypoplastic)
01/2013
1
Lymphopenia (Lymphocytopenia)
03/2012
1
Chromosome Aberrations (Chromosome Abnormalities)
07/2010
1
Agranulocytosis (Granulocytopenia)
06/2010
1
Disease Progression
12/2008
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2007
1
Septic Shock (Toxic Shock Syndrome)
11/2007
1
Hydrocephalus (Hydrocephaly)
05/2005
Drug/Important Bio-Agent (IBA)
4
Cytokines
IBA
04/2016 - 03/2006
3
Biological Products
IBA
12/2017 - 06/2011
2
Azacitidine (5 Azacytidine)
FDA Link
01/2021 - 01/2020
1
Vaccines
IBA
02/2022
1
Rituximab (Mabthera)
FDA Link
01/2021
1
Biomarkers (Surrogate Marker)
IBA
02/2019
1
Amphotericin B (Amphotericin)
FDA Link
Generic
11/2018
1
posaconazole
FDA Link
11/2018
1
Iron
IBA
01/2018
1
Immunoglobulin M (IgM)
IBA
12/2017
1
Immunoglobulins (Immunoglobulin)
IBA
10/2017
1
Antibodies
IBA
06/2015
1
Biocompatible Materials (Biomaterials)
IBA
01/2014
1
Interleukin-7 (Interleukin 7)
IBA
03/2012
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
03/2012
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
06/2011
1
eltrombopag
FDA Link
03/2011
1
Thrombopoietin Receptors
IBA
03/2011
1
Deferiprone
IBA
06/2010
1
Pharmaceutical Preparations
IBA
06/2010
1
Lenalidomide (CC 5013)
FDA Link
03/2010
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2009
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
12/2009
1
Fas Ligand Protein (Fas Ligand)
IBA
12/2009
1
Transforming Growth Factor beta1 (TGF beta 1)
IBA
12/2009
1
Autoantibodies
IBA
12/2008
1
Anti-Bacterial Agents (Antibiotics)
IBA
11/2007
1
Erythropoietin Receptors (Erythropoietin Receptor)
IBA
10/2006
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
03/2006
1
Immunosorbents
IBA
03/2006
1
Stem Cell Factor
IBA
03/2006
1
Enzymes
IBA
03/2006
1
flt3 ligand protein (flt3 ligand)
IBA
03/2006
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
06/2010 - 05/2005
2
Therapeutics
03/2010 - 12/2008
1
Thrombectomy
02/2022
1
Palliative Care (Palliative Therapy)
11/2021
1
Length of Stay
03/2021
1
Cystectomy
03/2021
1
Treatment Delay
01/2021
1
Drug Tapering
01/2021
1
Stem Cell Transplantation
02/2019
1
Thyroidectomy
06/2015
1
Cardiomyoplasty
01/2014
1
Remission Induction
11/2007
1
Debridement
11/2007
1
Radiotherapy
05/2005